| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 177 |
| 1 | INFLIXIMAB | 112 |
| 2 | VEDOLIZUMAB | 73 |
| 3 | METHOTREXATE SODIUM | 65 |
| 4 | METHOTREXATE | 58 |
| 5 | AZATHIOPRINE | 57 |
| 6 | PREDNISONE | 40 |
| 7 | USTEKINUMAB | 39 |
| 8 | ADALIMUMAB-ADAZ | 38 |
| 9 | ISOTRETINOIN | 37 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ESTRONE | 1 | 0.0093 |
| 1 | ERYTHROMYCIN AND BENZOYL PEROXIDE | 1 | 0.0062 |
| 2 | PROPYLTHIOURACIL | 9 | 0.0043 |
| 3 | ADALIMUMAB-AACF | 1 | 0.0030 |
| 4 | PHENOBARBITAL SODIUM | 1 | 0.0024 |
| 5 | BALSALAZIDE DISODIUM | 1 | 0.0019 |
| 6 | BEPOTASTINE BESILATE | 1 | 0.0016 |
| 7 | CYCLOPENTOLATE HYDROCHLORIDE | 1 | 0.0015 |
| 8 | FLECAINIDE ACETATE | 8 | 0.0015 |
| 9 | INFLIXIMAB-AXXQ | 1 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 132 |
| 1 | Integrin Receptor Antagonist [EPC] | 73 |
| 2 | Corticosteroid [EPC] | 66 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 58 |
| 4 | Purine Antimetabolite [EPC] | 57 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 43 |
| 6 | Interleukin-12 Antagonist [EPC] | 39 |
| 7 | Interleukin-23 Antagonist [EPC] | 39 |
| 8 | Retinoid [EPC] | 37 |
| 9 | Vitamin B12 [EPC] | 28 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Thyroid Hormone Synthesis Inhibitor [EPC] | 9 | 0.0009 |
| 1 | Integrin Receptor Antagonist [EPC] | 73 | 0.0008 |
| 2 | GLP-2 Analog [EPC] | 9 | 0.0007 |
| 3 | Purine Antimetabolite [EPC] | 57 | 0.0006 |
| 4 | Interleukin-1 Receptor Antagonist [EPC] | 9 | 0.0005 |
| 5 | Interleukin-12 Antagonist [EPC] | 39 | 0.0004 |
| 6 | Interleukin-23 Antagonist [EPC] | 39 | 0.0004 |
| 7 | Progesterone [EPC] | 8 | 0.0003 |
| 8 | Bile Acid Sequestrant [EPC] | 3 | 0.0002 |
| 9 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |